Immunic, Inc., a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, announced participation in the following scientific and industry conferences in November.
Immunic to Participate in Scientific and Industry Conferences in November 2023 Read More »
Invertir en criptomonedas se ha vuelto más accesible y eficiente con la ayuda de la Inteligencia Artificial (IA). La gestión de inversiones en criptomonedas impulsada por IA utiliza algoritmos de aprendizaje automático para analizar las tendencias del mercado, lo que conduce a m …
Inteligencia artificial y la gestión de inversión en criptomonedas Read More »
Caris Life Sciences® announced that Sarah Cannon Research Institute, one of the world’s leading oncology research organizations conducting community-based clinical trials, has joined the Caris Precision Oncology Alliance™.
The Caris Precision Oncology Alliance Welcomes Sarah Cannon Research Institute Read More »
Virion Therapeutics, LLC and its Joint Venture partner, Ocean Biomedical, Inc., announced that the first patients have been dosed in the Phase 1b clinical trial of its investigational VRON-0200 immunotherapy, which is being evaluated as a functional cure for patients with chronic Hepatitis B virus infection.
In the third quarter of 2023, BioInvent achieved a significant landmark with the recruitment of the first patient to the BI-1808 single agent Phase 2a study.
BioInvent International AB: Interim report January–September 2023 Read More »
El oxígeno es un elemento vital para el funcionamiento de nuestro organismo, y el cerebro, como centro de control de todas las funciones corporales, es especialmente sensible a su suministro adecuado. Vamos a explorar cómo afecta la falta de oxígeno al cerebro, un fenómen …
ChemDiv is excited to announce the expansion of its Business Development Team with the addition of two seasoned professionals, Peter Dmitriev as Business Development Manager and David Stark as Senior Regional Director of Business Development.
MaaT Pharma announced that the DSMB unanimously recommended that the open-label, single arm pivotal Phase 3 clinical trial evaluating MaaT013 in acute Graft-versus-Host Disease, named ARES, continues without modification.
Hansa Biopharma, the pioneer in immunomodulatory enzyme technology for rare IgG mediated diseases, announced its business update and interim report for January to September 2023.
Hansa Biopharma Interim Report January-September 2023 Read More »
La vista desde el espacio ofrece una perspectiva única de nuestro planeta, revelando la increíble capacidad de la humanidad para dejar su huella en la Tierra. En este texto exploraremos algunas de las estructuras humanas más impresionantes que pueden verse desde el espacio, evid …
¿Qué estructuras humanas pueden verse desde el espacio? Read More »
